From: CT findings of 795 COVID-19 positive cases: a multicenter study in Egypt
Imaging finding | No. of patients (%) |
---|---|
Pulmonary | |
Old granulomatous infection (apical scarring/calcified nodules) | 73 (8.47%) |
Cysts | 7 (0.8%) |
Airway disease | 92 (10.67%) |
Mediastinal | |
Lymphadenopathy: calcified/noncalcified | 47 (5.5%)/37 (4.3%)/10 (1.2%) |
Pericardial effusion | 39 (4.52%) |
Cardiomegaly | 123 (14.27%) |
Pulmonary hypertension | 42 (4.87%) |
Anterior mediastinal mass | 1 (0.12%) |
Mediastinal bronchogenic cyst | 1 (0.12%) |
Tracheal diverticulum | 5 (0.58%) |
Thymic hyperplasia | 123 (14.3%) |
Atheromatous vascular plaques | 111 (12.88%) |
Ectatic ascending aorta | 17 (1.97%) |
Lipomatosis | 1 (0.12%) |
Median sternotomy sutures | 3 (0.35%) |
Enlarged heterogeneous thyroid gland | 48 (5.57%) |
Patulous esophagus | 3 (0.35%) |
Pleural | |
Effusion | 27 (3.1%) |
Thickening/reaction | 105 (12.2%) |
Calcified plaques (Asbestos exposure) | 2 (0.23%) |
Chest wall | |
Breast mass | 4 (0.46%) |
Abdominal | |
Liver cirrhosis | 17 (1.97%) |
Fatty liver | 69 (8%) |
Hepatomegaly/Splenomegaly | 14 (1.62%)/13 (1.51%) |
Hepatic/Splenic calcified focus | 9 (1%) |
Hepatic/splenic focal lesion | 9 (1%) |
Adrenal mass | 10 (1.16%) |
Renal stone and backpressure changes | 21 (2.4%) |
Renal cortical cyst | 14 (1.62%) |
Renal atrophic changes | 3 (0.35%) |
Ascites | 1 (0.12%) |
Calcular gall bladder | 26 (3.02%) |